Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

In vitro effects of photodynamic therapy induced by chloroaluminum phthalocyanine nanoemulsion

Full text
Author(s):
Franchi, Leonardo Pereira ; Amantino, Camila F. ; Melo, Maryanne T. ; de Lima Montaldi, Ana Paula ; Primo, Fernando L. ; Tedesco, Antonio Claudio
Total Authors: 6
Document type: Journal article
Source: Photodiagnosis and Photodynamic Therapy; v. 16, p. 100-105, DEC 2016.
Web of Science Citations: 3
Abstract

Background: The photodynamic therapy (PDT) has been used to treat cancer mainly by inducing oxidative stress. Our aim was to evaluate the effect of PDT and its combination with methoxyamine (MX), a blocker of base excision repair (BER), in cells expressing high levels of the APE1 protein, which is involved in cell oxidative damage response. Methods: The HeLa and A549 cells were treated for 3 h with chloroaluminum phthalocyanine incorporated into a well-designed nanoemulsion (C1A1Pc/NE); and then irradiated by visible light (@670 nm) with doses of 0.1, 0.5 and 1.0 J/cm(2). A simultaneous combination of MX+CIA1Pc/NE was performed and then irradiated with the selected dose of 0.5 J/cm(2) . The treatments were evaluated in terms of viability, clonogenicity, DNA fragmentation, and cell death mechanism by apoptosis and/or necrosis. Results: The APE1 protein expression observed was higher in HeLa than in A549. Both cell lines exhibited substantial differences in cell cytotoxicity. The PDT decreased the clonogenicity of HeLa by inducing apoptosis (sub-G1 and annexin detection). Additionaly, the MX potentiates the PDT-effects in HeLa. Otherwise, low cytotoxicity was observed in A549 cells. Conclusion: The PDT induced apoptosis in high APE1 expressive HeLa cells, and the blockage of BER by MX increased its effects. (C) 2016 Elsevier B.V. All rights reserved. (AU)

FAPESP's process: 13/50181-1 - Use of drugs containing nanocarriers with photosensitizers and/or other active compounds applied to cell therapy and treatment of central nervous system disorders
Grantee:Antonio Claudio Tedesco
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 14/11870-9 - Sensitizing cancer cell lines to photodynamic therapy through inhibition of protein APE1
Grantee:Leonardo Pereira Franchi
Support Opportunities: Scholarships in Brazil - Post-Doctoral